Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-15-051469

Director sold 10,000 shares at $7.26 ($72,631)

  • Director acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kraus Al · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2015-08-20 Exercise or conversion : show line 1 in the form +10,000 $0.88 $8,750 65,746 D
2015-08-20 Sale : show line 2 in the form −10,000 $7.26 $72,631 55,746 D
Open-market sales · 10,000 sh · avg $7.26 · $72,631

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2015-08-20 Exercise or conversion : show line 3 in the form Stock Option −10,000 86,773 D
Loading xslF345X03/v418876_4.xml…